China Orders Recall Of Batch Of Intravenous Needles
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities announced another medical-device recall, this time of intravenous needles that could snap off in the skin of patients. The food and drug administrations of Shanghai and Guangdong ordered 47,700 of the disposable needles recalled. That is more than half of a suspected batch of the needles made by Damei Medicinal Plastic Factory in Shanghai. The recall began when one snapped off and became embedded in the scalp of an infant. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.